John K. Cini - 15 Dec 2021 Form 4 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role
Chief Scientific Officer
Signature
/s/ John Harry Cross III, power of attorney
Issuer symbol
SONN
Transactions as of
15 Dec 2021
Net transactions value
$0
Form type
4
Filing time
08 Apr 2022, 16:30:45 UTC
Previous filing
28 May 2021
Next filing
22 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SONN Common Stock Award +80,034 +36% 304,101 15 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 15, 2021, the Reporting Person was granted 80,034 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2023.